Inovio Pharmaceuticals Stock Technical Analysis
| INO Stock | USD 4.07 0.01 0.25% |
As of the 24th of November, Inovio Pharmaceuticals retains the Risk Adjusted Performance of (0.19), standard deviation of 3.34, and Market Risk Adjusted Performance of (0.41). Inovio Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Inovio Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Inovio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InovioInovio |
Inovio Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 1.25 | Buy | 6 | Odds |
Most Inovio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Inovio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Inovio Pharmaceuticals, talking to its executives and customers, or listening to Inovio conference calls.
Inovio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Inovio Pharmaceuticals Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Inovio Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Inovio Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Inovio Pharmaceuticals. You can use it to identify possible trend reversals for Inovio Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Inovio Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Inovio Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Inovio Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.04 , which may imply that the returns on investment in Inovio Pharmaceuticals will continue to fail. It has 122 observation points and a regression sum of squares at 52.64, which is the sum of squared deviations for the predicted Inovio Pharmaceuticals price change compared to its average price change.About Inovio Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Inovio Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Inovio Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Inovio Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Inovio Pharmaceuticals. By analyzing Inovio Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Inovio Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Inovio Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 5.9E-5 | 5.6E-5 | Price To Sales Ratio | 163.1 | 154.95 |
Inovio Pharmaceuticals November 24, 2024 Technical Indicators
Most technical analysis of Inovio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Inovio from various momentum indicators to cycle indicators. When you analyze Inovio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 2.38 | |||
| Coefficient Of Variation | (396.45) | |||
| Standard Deviation | 3.34 | |||
| Variance | 11.18 | |||
| Information Ratio | (0.29) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (1.38) | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 17.45 | |||
| Value At Risk | (7.07) | |||
| Potential Upside | 3.22 | |||
| Skewness | (0.66) | |||
| Kurtosis | 1.9 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.55) | Return On Assets (0.40) | Return On Equity (0.91) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.